GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Vital KSK Holdings Inc (TSE:3151) » Definitions » Peter Lynch Fair Value

Vital KSK Holdings (TSE:3151) Peter Lynch Fair Value : 円1,310.09 (As of May. 11, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vital KSK Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Vital KSK Holdings's PEG is 1. Vital KSK Holdings's 5-Year TTM EBITDA Growth Rate is 13.68. Vital KSK Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円95.77. Therefore, the Peter Lynch Fair Value for today is 円1,310.09.

As of today (2024-05-11), Vital KSK Holdings's share price is 円1200.00. Vital KSK Holdings's Peter Lynch fair value is 円1,310.09. Therefore, Vital KSK Holdings's Price to Peter Lynch Fair Value Ratio for today is 0.92.


The historical rank and industry rank for Vital KSK Holdings's Peter Lynch Fair Value or its related term are showing as below:

TSE:3151' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.41   Med: 0.88   Max: 1.59
Current: 0.92


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Vital KSK Holdings was 1.59. The lowest was 0.41. And the median was 0.88.


TSE:3151's Price-to-Peter-Lynch-Fair-Value is ranked better than
52.63% of 38 companies
in the Medical Distribution industry
Industry Median: 0.935 vs TSE:3151: 0.92

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Vital KSK Holdings Peter Lynch Fair Value Historical Data

The historical data trend for Vital KSK Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vital KSK Holdings Peter Lynch Fair Value Chart

Vital KSK Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vital KSK Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 629.81 1,310.09

Competitive Comparison of Vital KSK Holdings's Peter Lynch Fair Value

For the Medical Distribution subindustry, Vital KSK Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's Price-to-Peter-Lynch-Fair-Value falls into.



Vital KSK Holdings Peter Lynch Fair Value Calculation

Vital KSK Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 13.68 *95.767
=1,310.09

Vital KSK Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円95.77.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Vital KSK Holdings  (TSE:3151) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 13.68 instead of 15 in this case.

Vital KSK Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=1200.00/1,310.09
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vital KSK Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Vital KSK Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vital KSK Holdings (TSE:3151) Business Description

Traded in Other Exchanges
N/A
Address
1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.

Vital KSK Holdings (TSE:3151) Headlines

No Headlines